Pular para o conteúdo

Wan Amir-Jeffery bin Wan Abdul Majid

Chief Strategy Officer

Age: 45 years

Nationality: Malaysian


  • Bachelor of Business Administration - International Trade, University of Central Arkansas, United States of America

Working Experience and Occupation

Wan Amir-Jeffery began his career in a marine and environmental consulting firm called Sea Resources Management (“SRM”) Sdn. Bhd. in 1997. In 2007, he left SRM

to join Malaysian Biotechnology Corporation (“BiotechCorp”) Sdn. Bhd. as Lead Business Analyst, Biomedical Business Development and Investment (“BDI”) Division. At BiotechCorp, he developed his knowledge and expertise in identifying, structuring, securing and implementing biomedical investment projects, especially in the biopharma and pharmaceutical industries. He was promoted to Vice-President within the same division in 2008.

In 2013, he assumed the dual role of Chief Executive Officer of Johor Biotechnology & Biodiversity Corporation and J-Biotech Holdings Sdn. Bhd. He was responsible for developing and implementing key bioeconomy and biotech initiatives in Johor. Wan Amir-Jeffery joined CCM Duopharma Biotech Berhad as Chief Strategy Officer on 5 September 2016, responsible for business development, Halal initiatives and government business of CCMD Group. He is also the Chief Executive Officer of Duopharma (M) Sdn. Bhd., a wholly owned subsidiary of CCMD since 5 September 2016.

Billy Urudra Chief Commercial Officer
Chek Wu Kong Chief Financial Officer
Wan Amir-Jeffery bin Wan Abdul Majid Chief Strategy Officer
Ng Su Yee Chief Technical Officer
Krisnakumara-Reddi Chief Manufacturing Officer
Ibrahim Hussin Salleh Chief Legal Officer and Group Company Secretary

Last updated : 26 Feb 2018

© Copyright 2018 CCM Duopharma Biotech Berhad. All Rights Reserved.